Olaparib as Maintenance Treatment Following First-line Platinum-based
Chemotherapy (PBC) in Patients With a Germline BRCA Mutation and
Metastatic Pancreatic Cancer (mPC): Phase III POLO Trial
Document type:
Meeting Abstract
Author(s):
Golan, T.; Hammel, P.; Reni, M.; Van Cutsem, E.; Macarulla, T.; Hall, M. J.; Park, J. O.; Hochhauser, D.; Arnold, D.; Oh, D. Y.; Reinacher-Schick, A.; Tortora, G.; Alguel, H.; O'Reilly, E. M.; McGuinness, D.; Cui, K. Y.; Schlienger, K.; Locker, G. Y.; Kindler, H. L.